Rare earth stocks continue to draw strong investor attention, and Wall Street remains optimistic about the sector’s long-term prospects. On Monday, William Blair analyst Neal Dingmann initiated coverage of USA Rare Earth (USAR) with an outperform rating, citing expectations that the US government will continue investing in domestic rare earth producers. Shares of USA Rare

Wall Street opened higher on Monday as investors’ sentiment seems upbeat about the upcoming slew of earnings and the possibility of another rate cut by the Federal Reserve. The Dow Jones Industrial Average gained 194 points, or 0.4%, while the S&P 500 rose 0.6% and the Nasdaq Composite added 0.8%. An optimistic signal from the

Biotech stocks are lighting up the tape today, with several clinical-stage companies posting double-digit gains on fresh catalysts. From earnings beats to promising trial data and billion-dollar partnerships, investors are rewarding progress across oncology, immunology, and drug delivery platforms. Here’s a quick look at four making the biggest move on Monday: CorMedix, RAPT Therapeutics, Celcuity,

Tesla stock (NASDAQ: TSLA) advanced on Monday, as investors positioned themselves ahead of the electric vehicle maker’s third-quarter earnings report scheduled for Wednesday, October 22. The stock rose approximately over 2% to $448.32 in early trading, continuing a robust rally that has seen shares climb over 30% in the past three months and roughly 80%

Japanese stocks surged to fresh highs on Monday, with the Nikkei 225 jumping 3.37% to close at 49,185.5 and the broader Topix gaining 2.46% to end at 3,248.45. The rally came after reports that the Liberal Democratic Party and the Japan Restoration Party reached a coalition agreement, potentially ushering in a more stable and reform-oriented

This week brought a mix of political stalemate, global diplomacy, and market unease as Washington remained mired in a prolonged government shutdown, President Donald Trump took a victory lap over a Middle East cease-fire, and renewed credit worries rattled US regional banks. Meanwhile, Wall Street’s largest lenders continued to post robust quarterly results, tempering investor

Oracle stock (NYSE: ORCL) tumbled 6.5% on Friday, wiping billions from the market value of the enterprise software giant as investors parsed the company’s long-term AI and cloud ambitions against the short-term costs of scaling. The stock swung sharply after an analyst event in Las Vegas where management laid out aggressive revenue and cloud-infrastructure targets,

Heathrow Airport is preparing for a major leadership transition as former BT Group chief executive Philip Jansen emerges as the frontrunner to become its next chairman, reported Sky News. The move comes as Britain’s largest aviation hub pushes ahead with a long-awaited £50 billion expansion plan, including the construction of a third runway and significant

Zions Bancorporation (NASDAQ: ZION) nosedived this week after reporting a $50 million write-off tied to fraudulent loans. The sell-off wiped over $1 billion off its market cap in recent sessions. The regional bank’s announcement sparked investor anxiety over its lending standards and broader credit risk across the financial sector. However, a senior Baird analyst, David

A turbulent Friday across Europe as the BBC faces a formal rebuke from Ofcom over a “misleading” Gaza documentary, Spanish police reopen the Mango founder’s death as a homicide case, UK bank stocks plunge amid US financial jitters, and Ferrari reins in UK sales following the end of Britain’s non-dom tax regime. Here’s a glance